A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.

Maximilian Niyazi; Adriana Pitea; Michel Mittelbronn; Joachim Steinbach; Carsten Sticht; Franz Zehentmayr; Daniel Piehlmaier; Horst Zitzelsberger; Ute Ganswindt; Claus Rödel; Kirsten Lauber; Claus Belka; Kristian Unger

doi:10.18632/oncotarget.9945

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.

Maximilian Niyazi, Adriana Pitea, Michel Mittelbronn, Joachim Steinbach, Carsten Sticht, Franz Zehentmayr (Co-author), Daniel Piehlmaier, Horst Zitzelsberger, Ute Ganswindt, Claus Rödel, Kirsten Lauber, Claus Belka, Kristian Unger

Department of Radiotherapy and Radiation Oncology

Research output: Contribution to journal › Original Article › peer-review

37 Citations (Web of Science)

Original language	English
Pages (from-to)	45764-45775
Journal	Oncotarget
Volume	7
Issue number	29
DOIs	https://doi.org/10.18632/oncotarget.9945
Publication status	Published - 2016

Keywords

NEWLY-DIAGNOSED GLIOBLASTOMA
INTRATUMORAL HOMOGENEITY
ADJUVANT TEMOZOLOMIDE
CELL-DIFFERENTIATION
MICRORNA EXPRESSION
GLIOMA PATIENTS
BEVACIZUMAB
SURVIVAL
RNA
RADIOTHERAPY

Access to Document

10.18632/oncotarget.9945

Cite this

@article{ce5e07bf181d497fb6b7d98967f07b40,

title = "A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.",

keywords = "NEWLY-DIAGNOSED GLIOBLASTOMA, INTRATUMORAL HOMOGENEITY, ADJUVANT TEMOZOLOMIDE, CELL-DIFFERENTIATION, MICRORNA EXPRESSION, GLIOMA PATIENTS, BEVACIZUMAB, SURVIVAL, RNA, RADIOTHERAPY",

author = "Maximilian Niyazi and Adriana Pitea and Michel Mittelbronn and Joachim Steinbach and Carsten Sticht and Franz Zehentmayr and Daniel Piehlmaier and Horst Zitzelsberger and Ute Ganswindt and Claus R{\"o}del and Kirsten Lauber and Claus Belka and Kristian Unger",

note = "Zehentmayr: Department of Radiation Oncology, Paracelsus Medical University, Salzburg, Austria",

year = "2016",

doi = "10.18632/oncotarget.9945",

language = "English",

volume = "7",

pages = "45764--45775",

journal = "Oncotarget",

issn = "1949-2553",

number = "29",

}

TY - JOUR

T1 - A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.

AU - Niyazi, Maximilian

AU - Pitea, Adriana

AU - Mittelbronn, Michel

AU - Steinbach, Joachim

AU - Sticht, Carsten

AU - Zehentmayr, Franz

AU - Piehlmaier, Daniel

AU - Zitzelsberger, Horst

AU - Ganswindt, Ute

AU - Rödel, Claus

AU - Lauber, Kirsten

AU - Belka, Claus

AU - Unger, Kristian

N1 - Zehentmayr: Department of Radiation Oncology, Paracelsus Medical University, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - NEWLY-DIAGNOSED GLIOBLASTOMA

KW - INTRATUMORAL HOMOGENEITY

KW - ADJUVANT TEMOZOLOMIDE

KW - CELL-DIFFERENTIATION

KW - MICRORNA EXPRESSION

KW - GLIOMA PATIENTS

KW - BEVACIZUMAB

KW - SURVIVAL

KW - RNA

KW - RADIOTHERAPY

U2 - 10.18632/oncotarget.9945

DO - 10.18632/oncotarget.9945

M3 - Original Article

C2 - 27302927

SN - 1949-2553

VL - 7

SP - 45764

EP - 45775

JO - Oncotarget

JF - Oncotarget

IS - 29

ER -